| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 1 | 1 | 1 2001 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 126(37):1002-1004
Krug A; Hartmann G
Specific modification of the immune system with CpG- oligonucleotides | 1 | 0
|
| 2 | 1 | 2 2001 JOURNAL OF EXPERIMENTAL MEDICINE 194(12):1823-1834
Dzionek A; Sohma Y; Nagafune J; Cella M; Colonna M; Facchetti F; Gunther G; Johnston I; Lanzavecchia A; Nagasaka T; Okada T; Vermi W; Winkels G; Yamamoto T; Zysk M; Yamaguchi Y; Schmitz J
BDCA-2, a novel plasmacytoid dendritic cell-specific type IIC- type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction | 26 | 1
|
| 3 | 1 | 3 2001 NATURE REVIEWS IMMUNOLOGY 1(2):135-145
Medzhitov R
Toll-like receptors and innate immunity | 69 | 7
|
| 4 | 0 | 4 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(16):9237-9242
Bauer S; Kirschning CJ; Hacker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
Human TLR9 confers responsiveness to bacterial DNA via species- specific CpG motif recognition | 97 | 98
|
| 5 | 1 | 5 2001 TRENDS IN MOLECULAR MEDICINE 7(12):566-572
Zhu DL; Rice J; Savelyeva N; Stevenson FK
DNA fusion vaccines against B-cell tumors | 2 | 0
|
| 6 | 1 | 6 2002 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 88(3):253-264
Uthaisangsook S; Day NK; Bahna SL; Good RA; Haraguchi S
Innate immunity and its role against infections | 1 | 0
|
| 7 | 1 | 7 2002 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 88(6):543-548
Modlin RL
Mammalian toll-like receptors | 0 | 0
|
| 8 | 1 | 8 2002 ANNUAL REVIEW OF IMMUNOLOGY 20():709-760
Krieg AM
CpG motifs in bacterial DNA and their immune effects | 32 | 9
|
| 9 | 2 | 9 2002 ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT 12(3):165-175
Vollmer J; Janosch A; Laucht M; Ballas ZK; Schetter C; Krieg AM
Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes | 0 | 0
|
| 10 | 1 | 10 2002 ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS 50(4):233-241
Bohle B
Allergen-specific T lymphocytes as targets for specific immunotherapy: Striking at the roots of type I allergy | 0 | 0
|
| 11 | 1 | 11 2002 BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY 16(6):851-867
Gewirtz AT; Liu YA; Sitaraman SV; Madara JL
Intestinal epithelial pathobiology: past, present and future | 0 | 0
|
| 12 | 1 | 12 2002 BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY 16(6):915-931
Shanahan F
The host-microbe interface within the gut | 0 | 0
|
| 13 | 1 | 13 2002 BIOCHEMICAL PHARMACOLOGY 64(5-6):985-992
Servant MJ; Grandvaux N; Hiscott J
Multiple signaling pathways leading to the activation of interferon regulatory factor 3 | 0 | 0
|
| 14 | 1 | 14 2002 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1589(1):1-13
Kaisho T; Akira S
Toll-like receptors as adjuvant receptors | 17 | 3
|
| 15 | 1 | 15 2002 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1592(3):265-280
Martin MU; Wesche H
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family | 0 | 0
|
| 16 | 5 | 16 2002 BIOCONJUGATE CHEMISTRY 13(5):966-974
Kandimalla ER; Bhagat L; Yu D; Cong YP; Tang J; Agrawal S
Conjugation of ligands at the 5 '-end of CpG DNA affects immunostimulatory activity | 2 | 0
|
| 17 | 1 | 17 2002 BIODRUGS 16(6):419-431
Dalpke A; Zimmermann S; Heeg K
CpG DNA in the prevention and treatment of infections | 0 | 0
|
| 18 | 3 | 18 2002 BIOLOGICAL CHEMISTRY 383(10):1491-1500
Dalpke A; Zimmermann S; Heeg K
Immunopharmacology of CpG DNA | 0 | 0
|
| 19 | 1 | 19 2002 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 8(12):648-655
Schultz KR; Su WN; Hsiao CC; Doho G; Jevon G; Bader S; MacFarlane DE; Gilman AL
Chloroquine prevention of murine MHC-disparate acute graft- versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterations in T-cell cytokine production | 0 | 0
|
| 20 | 1 | 20 2002 BIOSCIENCE REPORTS 22(2):309-322
Wilson A; Pitt B; Li S
Complex roles of CpG in liposomal delivery of DNA and oligonucleotides | 1 | 0
|
| 21 | 5 | 21 2002 BIOTECHNIQUES ():66-+
Ozato K; Tsujimura H; Tamura T
Toll-like receptor signaling and regulation of cytokine gene expression in the immune system | 0 | 0
|
| 22 | 1 | 22 2002 BLOOD 100(12):4169-4176
Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses | 0 | 0
|
| 23 | 1 | 23 2002 CELLS TISSUES ORGANS 172(2):86-95
Mirmohammadsadegh A; Maschke J; Basner-Tschakarjan E; Bar A; Hengge UR
Reaction of keratinocytes to exogenous DNA | 0 | 0
|
| 24 | 1 | 24 2002 CELLULAR IMMUNOLOGY 218(1-2):74-86
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu XH; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod | 0 | 0
|
| 25 | 1 | 25 2002 CELLULAR MICROBIOLOGY 4(2):61-72
Didierlaurent A; Sirard JC; Kraehenbuhl JP; Neutra MR
How the gut senses its content | 2 | 0
|
| 26 | 2 | 26 2002 CLINICAL AND EXPERIMENTAL ALLERGY 32(7):984-989
Sabroe I; Parker LC; Wilson AG; Whyte MKB; Dower SK
Toll-like receptors: their role in allergy and non-allergic inflammatory disease | 0 | 0
|
| 27 | 2 | 27 2002 COMPARATIVE MEDICINE 52(6):501-512
Liggitt D
Delivery of deoxyribonucleic acid (DNA) to somatic cells: An overview of species and strain-related responses | 0 | 0
|
| 28 | 1 | 28 2002 CRITICAL CARE 6(2):125-136
Opal SM; Huber CE
Bench-to-bedside review: Toll-like receptors and their role in septic shock | 5 | 1
|
| 29 | 1 | 29 2002 CRITICAL CARE MEDICINE 30(1):S1-S11
Lien E; Ingalls RR
Toll-like receptors | 12 | 1
|
| 30 | 4 | 30 2002 CRITICAL REVIEWS IN IMMUNOLOGY 22(3):217-250
Dalpke A; Heeg K
Signal integration following toll-like receptor triggering | 0 | 0
|
| 31 | 1 | 31 2002 CURRENT OPINION IN IMMUNOLOGY 14(1):103-110
Underhill DM; Ozinsky A
Toll-like receptors: key mediators of microbe detection | 45 | 0
|
| 32 | 3 | 32 2002 CURRENT OPINION IN IMMUNOLOGY 14(3):373-379
Colonna M; Krug A; Cella M
Interferon-producing cells: on the front line in immune responses against pathogens | 11 | 1
|
| 33 | 1 | 33 2002 CURRENT OPINION IN IMMUNOLOGY 14(4):413-419
Bachmann MF; Kopf M
Balancing protective immunity and immunopathology | 0 | 0
|
| 34 | 1 | 34 2002 CURRENT OPINION IN MICROBIOLOGY 5(1):62-69
Wagner H
Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity | 14 | 3
|
| 35 | 1 | 35 2002 CURRENT OPINION IN RHEUMATOLOGY 14(4):373-382
Pacheco-Tena C; Zhang X; Stone M; Burgos-Vargas R; Inman RD
Innate immunity in host-microbial interactions: Beyond B27 in the spondyloarthropathies | 0 | 0
|
| 36 | 1 | 36 2002 EUROPEAN JOURNAL OF IMMUNOLOGY 32(4):1182-1187
Spitzer JH; Visintin A; Mazzoni A; Kennedy MN; Segal DM
Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells | 3 | 1
|
| 37 | 1 | 37 2002 EUROPEAN JOURNAL OF IMMUNOLOGY 32(5):1212-1222
Stunz LL; Lenert P; Peckham D; Yi AK; Haxhinasto S; Chang M; Krieg AM; Ashman RF
Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells | 1 | 1
|
| 38 | 1 | 38 2002 EUROPEAN JOURNAL OF IMMUNOLOGY 32(7):1958-1968
Ahmad-Nejad P; Hacker H; Rutz M; Bauer S; Vabulas RM; Wagner H
Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments | 6 | 0
|
| 39 | 2 | 39 2002 EUROPEAN JOURNAL OF IMMUNOLOGY 32(8):2356-2364
Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
CpG-DNA aided cross-presentation of soluble antigens by dendritic cells | 0 | 0
|
| 40 | 1 | 40 2002 EUROPEAN JOURNAL OF IMMUNOLOGY 32(11):3235-3245
Heckelsmiller K; Beck S; Rall K; Sipos B; Schlamp A; Tuma E; Rothenfusser S; Endres S; Hartmann G
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy | 0 | 0
|
| 41 | 1 | 41 2002 EXPERT OPINION ON BIOLOGICAL THERAPY 2(8):929-942
Bot A; Phillips WJ; von Herrath M
Antigen-based immune modulation: DNA vectors and beyond | 0 | 0
|
| 42 | 1 | 42 2002 EXPERT OPINION ON INVESTIGATIONAL DRUGS 11(12):1795-1812
Manocha S; Feinstein D; Kumar A; Kumar A
Novel therapies for sepsis: antiendotoxin therapies | 0 | 0
|
| 43 | 2 | 43 2002 EXPERT OPINION ON THERAPEUTIC PATENTS 12(3):341-367
Dumont FJ
Modulation of Th1 and Th2 responses for immunotherapy | 1 | 0
|
| 44 | 5 | 44 2002 HUMAN IMMUNOLOGY 63(12):1103-1110
Hochrein H; O'Keeffe M; Wagner H
Human and mouse plasmacytoid dendritic cells | 0 | 0
|
| 45 | 3 | 45 2002 HUMAN IMMUNOLOGY 63(12):1111-1119
Rothenfusser S; Tuma E; Endres S; Hartmann G
Plasmacytoid dendritic cells: The key to CpG | 0 | 0
|
| 46 | 3 | 46 2002 HUMAN IMMUNOLOGY 63(12):1120-1125
Ito T; Amakawa R; Fukuhara S
Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance | 0 | 0
|
| 47 | 1 | 47 2002 IMMUNOLOGY 105(3):245-251
Hacker G; Redecke V; Hacker H
Activation of the immune system by bacterial CpG-DNA | 1 | 1
|
| 48 | 1 | 48 2002 IMMUNOLOGY OF INFECTION, SECOND EDITION 32():551-588
Lovgren-Bengtsson K; Fossum C
Preparation and use of adjuvants | 0 | 0
|
| 49 | 1 | 49 2002 INFECTION AND IMMUNITY 70(6):2828-2836
Campos-Neto A; Webb JR; Greeson K; Coler RN; Skeiky YAW; Reed SG
Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice | 3 | 0
|
| 50 | 1 | 50 2002 INFECTION AND IMMUNITY 70(9):4892-4896
Lorenz E; Patel DD; Hartung T; Schwartz DA
Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide | 0 | 0
|
| 51 | 3 | 51 2002 INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 129(3):198-203
Bohle B
CpG motifs as possible adjuvants for the treatment of allergic diseases | 0 | 0
|
| 52 | 1 | 52 2002 JOURNAL OF ENDOTOXIN RESEARCH 8(5):329-335
Beutler B
LPS in microbial pathogenesis: promise and fulfilment | 0 | 0
|
| 53 | 2 | 53 2002 JOURNAL OF EXPERIMENTAL MEDICINE 196(2):269-274
Ishii KJ; Takeshita F; Gursel I; Gursel M; Conover J; Nussenzweig A; Klinman DM
Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation | 0 | 0
|
| 54 | 1 | 54 2002 JOURNAL OF IMMUNOLOGY 168(1):392-399
Sweet MJ; Campbell CC; Sester DP; Xu DM; McDonald RC; Stacey KJ; Hume DA; Liew FY
Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages | 5 | 1
|
| 55 | 1 | 55 2002 JOURNAL OF IMMUNOLOGY 168(4):1659-1663
Verthelyi D; Kenney RT; Seder RA; Gam AA; Friedag B; Klinman DM
CpG oligodeoxynucleotides as vaccine adjuvants in primates | 12 | 4
|
| 56 | 1 | 56 2002 JOURNAL OF IMMUNOLOGY 168(9):4531-4537
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdorfer B; Giese T; Endres S; Hartmann G
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides | 21 | 8
|
| 57 | 1 | 57 2002 JOURNAL OF IMMUNOLOGY 168(10):4854-4863
Dalpke AH; Schafer MKH; Frey M; Zimmermann S; Tebbe J; Weihe E; Heeg K
Immunostimulatory CpG-DNA activates murine microglia | 2 | 1
|
| 58 | 1 | 58 2002 JOURNAL OF IMMUNOLOGY 168(12):5989-5992
Guillot L; Balloy V; McCormack FX; Golenbock DT; Chignard M; Si-Tahar M
Cutting edge: The immunostimulatory activity of the lung surfactant protein-A involves toll-like receptor 4 | 4 | 0
|
| 59 | 1 | 59 2002 JOURNAL OF IMMUNOLOGY 168(12):6136-6141
Jacinto R; Hartung T; McCall C; Li LW
Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: Distinct alterations in IL-1 receptor- associated kinase | 6 | 1
|
| 60 | 1 | 60 2002 JOURNAL OF IMMUNOLOGY 169(3):1516-1523
Takami M; Kim N; Rho J; Choi Y
Stimulation by toll-like receptors inhibits osteoclast differentiation | 0 | 0
|
| 61 | 2 | 61 2002 JOURNAL OF IMMUNOLOGY 169(8):4088-4093
Harton JA; Linhoff MW; Zhang JH; Ting JPY
Cutting edge: CATERPILLER: A large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains | 2 | 0
|
| 62 | 1 | 62 2002 JOURNAL OF LEUKOCYTE BIOLOGY 71(5):813-820
Gursel M; Verthelyi D; Gursel I; Ishii KJ; Klinman DM
Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide | 4 | 1
|
| 63 | 1 | 63 2002 JOURNAL OF MOLECULAR MEDICINE-JMM 80(6):377-383
Mirmohammadsadegh A; Maschke J; Basner-Tschakarjan E; Bar A; Hengge UR
Induction of acute phase response genes in keratinocytes following exposure to oligodeoxynucleotides | 0 | 0
|
| 64 | 1 | 64 2002 JOURNAL OF VIROLOGY 76(13):6568-6576
Gierynska M; Kumaraguru U; Eo SK; Lee S; Krieg A; Rouse BT
Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes | 1 | 0
|
| 65 | 2 | 65 2002 JOURNAL OF VIROLOGY 76(22):11387-11396
Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection | 0 | 0
|
| 66 | 1 | 66 2002 LUPUS 11(12):865-871
Deocharan B; Qing X; Beger E; Putterman C
Antigenic triggers and molecular targets for anti-double- stranded DNA antibodies | 0 | 0
|
| 67 | 1 | 67 2002 MICROBES AND INFECTION 4(9):887-895
Takeuchi O; Akira S
Genetic approaches to the study of Toll-like receptor function | 2 | 0
|
| 68 | 1 | 68 2002 MICROBES AND INFECTION 4(9):969-974
Brown WC; Corral RS
Stimulation of B lymphocytes, macrophages, and dendritic cells by protozoan DNA | 0 | 0
|
| 69 | 2 | 69 2002 MICROBES AND INFECTION 4(13):1281-1290
Bozza S; Gaziano R; Lipford GB; Montagnoli C; Bacci A; Di Francesco P; Kurup VP; Wagner H; Romani L
Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants | 0 | 0
|
| 70 | 2 | 70 2002 NATURE 420(6917):885-891
Cohen J
The immunopathogenesis of sepsis | 0 | 0
|
| 71 | 2 | 71 2002 NATURE IMMUNOLOGY 3(6):499-499
Jurk M; Heil F; Vollmer J; Schetter C; Krieg AM; Wagner H; Lipford G; Bauer S
HumanTLR7 orTLR8 independently confer responsiveness to the antiviral compound R-848 | 13 | 5
|
| 72 | 2 | 72 2002 NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY 76(9):833-836
Kitazawa H; Saito T
Discovery of immunostimulatory DNA motifs from lactic acid bacteria and their application to "Bio-Defence Foods" | 0 | 0
|
| 73 | 1 | 73 2002 NUCLEIC ACIDS RESEARCH 30(7):1613-1619
Yu D; Kandimalla ER; Zhao QY; Cong YP; Agrawal S
Immunostimulatory properties of phosphorothioate CpG DNA containing both 3 '-5 '- and 2 '-5 '-internucleotide linkages | 6 | 2
|
| 74 | 1 | 74 2002 SURGERY 131(5):477-483
Raeburn CD; Calkins CM; Zimmerman MA; Arya J; Barsness KA; Harken AH
Toll-like receptors and surgical disease | 0 | 0
|
| 75 | 1 | 75 2002 TOLL-LIKE RECEPTOR FAMILY MEMBERS AND THEIR LIGANDS 270():109-120
Beutler B
TLR4 as the mammalian endotoxin sensor | 0 | 0
|
| 76 | 1 | 76 2002 TOLL-LIKE RECEPTOR FAMILY MEMBERS AND THEIR LIGANDS 270():121-144
Kirschning CJ; Schumann RR
TLR2: Cellular sensor for microbial and endogenous molecular patterns | 0 | 0
|
| 77 | 2 | 77 2002 TOLL-LIKE RECEPTOR FAMILY MEMBERS AND THEIR LIGANDS 270():145-154
Bauer S; Wagner H
Bacterial CpG-DNA licenses TLR9 | 0 | 0
|
| 78 | 1 | 78 2002 TRENDS IN MICROBIOLOGY 10(10):S32-S37
Persing DH; Coler RN; Lacy MJ; Johnson DA; Baldridge JR; Hershberg RM; Reed SG
Taking toll: lipid A mimetics as adjuvants and immunomodulators | 0 | 0
|
| 79 | 1 | 79 2002 TRENDS IN MOLECULAR MEDICINE 8(3):114-121
Agrawal S; Kandimalla ER
Medicinal chemistry and therapeutic potential of CpG DNA | 6 | 2
|
| 80 | 1 | 80 2002 VACCINE 20(21-22):2764-2771
Wang YQ; Wang WY; Li N; Yu YZ; Cao XT
Activation of antigen-presenting cells by immunostimulatory plant DNA: a natural resource for potential adjuvant | 0 | 0
|
| 81 | 1 | 81 2002 WIENER KLINISCHE WOCHENSCHRIFT 114():1-8
Burdon D; Zabel P
Acute phase reaction and immunocompetence in sepsis and SIRS | 0 | 0
|
| 82 | 6 | 82 2003 BIOORGANIC & MEDICINAL CHEMISTRY 11(3):459-464
Yu D; Kandimalla ER; Zhao QY; Bhagat L; Cong YP; Agrawal S
Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA | 1 | 0
|
| 83 | 1 | 83 2003 CURRENT OPINION IN IMMUNOLOGY 15(1):5-11
Akira S
Mammalian Toll-like receptors | 0 | 0
|
| 84 | 1 | 84 2003 CURRENT PHARMACEUTICAL DESIGN 9(1):1-5
Gewirtz AT
Intestinal epithelial toll-like receptors: To protect. And serve? | 1 | 0
|
| 85 | 1 | 85 2003 FRONTIERS IN BIOSCIENCE 8():D55-D68
Moniz M; Ling M; Hung CF; Wu TC
HPV DNA vaccines | 0 | 0
|
| 86 | 5 | 86 2003 FRONTIERS IN BIOSCIENCE 8():E115-E127
Carpentier AF; Auf G; Delattre JY
CpG-oligonucleotides for cancer immunotherapy: Review of the literature and potential applications in malignant glioma | 0 | 0
|
| 87 | 2 | 87 2003 GENOMICS 81(1):85-91
Lazarus R; Klimecki WT; Raby BA; Vercelli D; Palmer LJ; Kwiatkowski DJ; Silverman EK; Martinez F; Weiss ST
Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three US ethnic groups and exploratory case- control disease association studies | 0 | 0
|
| 88 | 1 | 88 2003 IMMUNOLOGY 108(1):10-15
Ochoa MT; Legaspi AJ; Hatziris Z; Godowski PJ; Modlin RL; Sieling PA
Distribution of Toll-like receptor 1 and Toll-like receptor 2 in human lymphoid tissue | 0 | 0
|
| 89 | 3 | 89 2003 IMMUNOLOGY LETTERS 85(2):85-95
Akira S; Hemmi H
Recognition of pathogen-associated molecular patterns by TLR family | 0 | 0
|
| 90 | 1 | 90 2003 INFECTION AND IMMUNITY 71(1):40-46
Jiang WW; Baker HJ; Smith BF
Mucosal immunization with Helicobacter, CpG DNA, and cholera toxin is protective | 0 | 0
|
| 91 | 1 | 91 2003 INFECTION AND IMMUNITY 71(2):850-856
Nonnenmacher C; Dalpke A; Zimmermann S; Flores-de-Jacoby L; Mutters R; Heeg K
DNA from periodontopathogenic bacteria is immunostimulatory for mouse and human immune cells | 0 | 0
|
| 92 | 3 | 92 2003 JOURNAL OF IMMUNOLOGY 170(1):438-444
Koedel U; Angele B; Rupprecht T; Wagner H; Roggenkamp A; Pfister HW; Kirschning CJ
Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis | 0 | 0
|
| 93 | 2 | 93 2003 JOURNAL OF IMMUNOLOGY 170(2):1052-1061
Yeo SJ; Yoon JG; Hong SC; Yi AK
CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: Alterations in IL-1 receptor-associated kinase expression | 0 | 0
|
| 94 | 1 | 94 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(4):316-326
Okamoto M; Oshikawa T; Tano T; Ohe G; Furuichi S; Nishikawa H; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Involvement of toll-like receptor 4 signaling in interferon- gamma production and antitumor effect by streptococcal agent OK-432 | 0 | 0
|
| 95 | 1 | 95 2003 NATURE REVIEWS IMMUNOLOGY 3(1):79-84
Hein WR; Griebel PJ
A road less travelled: large animal models in immunological research | 0 | 0
|
| 96 | 1 | 96 2003 VACCINE 21(5-6):485-490
Hu ZL; Sun SH; Zhou FJ
The binding of CpG-oligodeoxynucleotides to cell-surface and its immunostimulatory activity are modulated by extracellular acidic pH | 0 | 0
|
| 97 | 3 | 97 2003 VACCINE 21(9-10):832-835
Di Marco S; Moisan J; Boghdady ML; Skamene E; Radzioch D
Recombinant congenic strains of mice: a new tool for the genetic dissection of efficacy and toxicity of adjuvants | 0 | 0
|
| 98 | 1 | 98 2003 VACCINE 21(9-10):990-995
Zimmermann S; Heeg K; Dalpke A
Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3 ' sequence modifications | 0 | 0
|